InvestorsHub Logo
Followers 8
Posts 1909
Boards Moderated 0
Alias Born 09/10/2012

Re: None

Tuesday, 03/01/2022 3:54:44 AM

Tuesday, March 01, 2022 3:54:44 AM

Post# of 212
Ouch Ouch Ouch!
Incyte expects to generate revenue of $2.3 billion-$2.4 billion in U.S. sales alone, while Inrebic, which was acquired by Bristol after it bought Celgene in 2019, generated about $74 million in sales last year.

"We currently model that the company could get 30% market share, leading to revenue of approximately $390 million," said JMP Securities analyst Benjamin Reni.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INCY News